Background & Aims: To investigate the efficacy and safety of certolizumab pegol (a polyethylene-glycolated Fab’ frag-ment of anti-tumor necrosis factor, CDP870
Background. Interkeukin-1 (IL-1) gene cluster polymorphisms that are thought to enhance the production of IL-1β are associated with an increased risk of gastri